Pritchard, Emma
Matthews, Philippa C.
Stoesser, Nicole http://orcid.org/0000-0002-4508-7969
Eyre, David W.
Gethings, Owen
Vihta, Karina-Doris
Jones, Joel
House, Thomas
VanSteenHouse, Harper
Bell, Iain
Bell, John I.
Newton, John N.
Farrar, Jeremy
Diamond, Ian
Rourke, Emma
Studley, Ruth
Crook, Derrick
Peto, Tim E. A.
Walker, A. Sarah
Pouwels, Koen B. http://orcid.org/0000-0001-7097-8950
Article History
Received: 6 May 2021
Accepted: 26 May 2021
First Online: 9 June 2021
Competing interests
: All authors have completed the International Committee of Medical Journal Editors uniform disclosure from atExternalRef removed. D.W.E. declares lecture fees from Gilead outside of the submitted work. E.P., P.C.M., N.S., D.W.E., J.I.B., D.C., T.E.A.P., A.S.W. and K.B.P. are employees of the University of Oxford but were not involved in the development or production of the ChAdOx1 vaccine. J.I.B. acts as an unpaid advisor to Her Majesty’s Government on COVID-19 but does not sit on the vaccine task force and is not involved in procurement decisions. J.I.B. also sits on the board of Oxford Sciences Innovation, which has an investment in Vaccitech, which will receive a royalty from the ChAdOx1 vaccine if/when it makes a profit. H.V. reports personal fees from BioSpyder Technologies outside of the submitted work. Besides the funding mentioned above, A.S.W. also received grants from the Medical Research Council UK during the conduct of the study. There are no other relationships or activities that could appear to have influenced the submitted work.